Clovis Oncology, Inc. Research and Development Expense (Excluding Acquired in Process Cost)
Clovis Oncology, Inc. reported Research and Development Expense (Excluding Acquired in Process Cost) of $30.79 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2022-11-09
- Clovis Oncology, Inc. research and development expense (excluding acquired in process cost) for the quarter ending 2022-09-30 was $30.79M, a 33.39% decline year-over-year.
- Clovis Oncology, Inc. research and development expense (excluding acquired in process cost) for the quarter ending 2022-06-30 was $36.43M, a 20.40% decline year-over-year.
- Clovis Oncology, Inc. research and development expense (excluding acquired in process cost) for the quarter ending 2022-03-31 was $42.25M, a 19.99% decline year-over-year.
- Clovis Oncology, Inc. research and development expense (excluding acquired in process cost) for the quarter ending 2021-12-31 was $41.82M, a 26.26% decline year-over-year.
- Clovis Oncology, Inc. research and development expense (excluding acquired in process cost) for fiscal 2021 was $186.60M, a 27.59% decline from fiscal 2020.
- Clovis Oncology, Inc. research and development expense (excluding acquired in process cost) for fiscal 2020 was $257.71M, a 8.98% decline from fiscal 2019.
- Clovis Oncology, Inc. research and development expense (excluding acquired in process cost) for fiscal 2019 was $283.15M, a 22.39% increase from fiscal 2018.
- Clovis Oncology, Inc. research and development expense (excluding acquired in process cost) for fiscal 2018 was $231.35M, a 62.35% increase from fiscal 2017.
| Period end | Research and Development Expense (Excluding Acquired in Process Cost) 3 month | Research and Development Expense (Excluding Acquired in Process Cost) 6 month | Research and Development Expense (Excluding Acquired in Process Cost) 9 month | Research and Development Expense (Excluding Acquired in Process Cost) 12 month | Research and Development Expense (Excluding Acquired in Process Cost) 35 month | Research and Development Expense (Excluding Acquired in Process Cost) 38 month | Research and Development Expense (Excluding Acquired in Process Cost) 41 month | Research and Development Expense (Excluding Acquired in Process Cost) 44 month | Research and Development Expense (Excluding Acquired in Process Cost) 47 month | Research and Development Expense (Excluding Acquired in Process Cost) 50 month | Research and Development Expense (Excluding Acquired in Process Cost) 53 month | Research and Development Expense (Excluding Acquired in Process Cost) 56 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $30.79M 10-Q · filed 2022-11-09 | $67.21M derived: sum of 2 quarters · filed 2022-11-09 | $109.46M 10-Q · filed 2022-11-09 | $151.28M derived: sum of 4 quarters · filed 2022-11-09 | ||||||||
| 2022-06-30 | $36.43M 10-Q · filed 2022-08-08 | $78.68M 10-Q · filed 2022-08-08 | $120.49M derived: sum of 3 quarters · filed 2022-08-08 | $166.71M derived: sum of 4 quarters · filed 2022-11-09 | ||||||||
| 2022-03-31 | $42.25M 10-Q · filed 2022-05-05 | $84.07M derived: sum of 2 quarters · filed 2022-05-05 | $130.29M derived: sum of 3 quarters · filed 2022-11-09 | $176.05M derived: sum of 4 quarters · filed 2022-11-09 | ||||||||
| 2021-12-31 | $41.82M 10-K · filed 2022-02-24 | $88.04M derived: sum of 2 quarters · filed 2022-11-09 | $133.80M derived: sum of 3 quarters · filed 2022-11-09 | $186.60M 10-K · filed 2022-02-24 | ||||||||
| 2021-09-30 | $46.22M 10-Q · filed 2022-11-09 | $91.98M derived: sum of 2 quarters · filed 2022-11-09 | $144.79M 10-Q · filed 2022-11-09 | $201.49M derived: sum of 4 quarters · filed 2022-11-09 | ||||||||
| 2021-06-30 | $45.76M 10-Q · filed 2022-08-08 | $98.56M 10-Q · filed 2022-08-08 | $155.27M derived: sum of 3 quarters · filed 2022-08-08 | $218.17M derived: sum of 4 quarters · filed 2022-08-08 | ||||||||
| 2021-03-31 | $52.80M 10-Q · filed 2022-05-05 | $109.51M derived: sum of 2 quarters · filed 2022-05-05 | $172.41M derived: sum of 3 quarters · filed 2022-05-05 | $242.29M derived: sum of 4 quarters · filed 2022-05-05 | ||||||||
| 2020-12-31 | $56.71M 10-K · filed 2022-02-24 | $119.61M derived: sum of 2 quarters · filed 2022-02-24 | $189.49M derived: sum of 3 quarters · filed 2022-02-24 | $257.71M 10-K · filed 2022-02-24 | ||||||||
| 2020-09-30 | $62.90M 10-K · filed 2022-02-24 | $132.78M derived: sum of 2 quarters · filed 2022-02-24 | $201.00M 10-Q · filed 2021-11-03 | $273.47M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||
| 2020-06-30 | $69.88M 10-K · filed 2022-02-24 | $138.10M 10-Q · filed 2021-08-04 | $210.57M derived: sum of 3 quarters · filed 2022-02-24 | $288.47M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||
| 2020-03-31 | $68.22M 10-K · filed 2022-02-24 | $140.69M derived: sum of 2 quarters · filed 2022-02-24 | $218.59M derived: sum of 3 quarters · filed 2022-02-24 | $289.34M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||
| 2019-12-31 | $72.47M 10-K · filed 2021-02-25 | $150.37M derived: sum of 2 quarters · filed 2021-02-25 | $221.12M derived: sum of 3 quarters · filed 2021-02-25 | $283.15M 10-K · filed 2022-02-24 | ||||||||
| 2019-09-30 | $77.90M 10-K · filed 2021-02-25 | $148.64M derived: sum of 2 quarters · filed 2021-02-25 | $210.67M 10-Q · filed 2020-11-05 | $281.88M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||
| 2019-06-30 | $70.75M 10-K · filed 2021-02-25 | $132.78M 10-Q · filed 2020-08-07 | $203.99M derived: sum of 3 quarters · filed 2021-02-25 | $267.87M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||
| 2019-03-31 | $62.03M 10-K · filed 2021-02-25 | $133.24M derived: sum of 2 quarters · filed 2021-02-25 | $197.13M derived: sum of 3 quarters · filed 2021-02-25 | $249.84M derived: sum of 4 quarters · filed 2021-02-25 | ||||||||
| 2018-12-31 | $71.21M 10-K · filed 2020-02-26 | $135.10M derived: sum of 2 quarters · filed 2020-02-26 | $187.80M derived: sum of 3 quarters · filed 2020-02-26 | $231.35M 10-K · filed 2021-02-25 | ||||||||
| 2018-09-30 | $63.89M 10-K · filed 2020-02-26 | $116.59M derived: sum of 2 quarters · filed 2020-02-26 | $160.14M 10-Q · filed 2019-11-07 | $198.16M derived: sum of 4 quarters · filed 2020-02-26 | ||||||||
| 2018-06-30 | $52.71M 10-K · filed 2020-02-26 | $96.25M 10-Q · filed 2019-08-02 | $134.27M derived: sum of 3 quarters · filed 2020-02-26 | $173.19M derived: sum of 4 quarters · filed 2020-02-26 | ||||||||
| 2018-03-31 | $43.54M 10-K · filed 2020-02-26 | $81.56M derived: sum of 2 quarters · filed 2020-02-26 | $120.49M derived: sum of 3 quarters · filed 2020-02-26 | $153.59M derived: sum of 4 quarters · filed 2020-02-26 | ||||||||
| 2017-12-31 | $38.02M 10-K · filed 2019-02-28 | $76.94M derived: sum of 2 quarters · filed 2019-02-28 | $110.05M derived: sum of 3 quarters · filed 2019-02-28 | $142.50M 10-K · filed 2020-02-26 | ||||||||
| 2017-09-30 | $38.92M 10-K · filed 2019-02-28 | $72.03M derived: sum of 2 quarters · filed 2019-02-28 | $104.48M 10-Q · filed 2018-11-01 | $158.93M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||
| 2017-06-30 | $33.11M 10-K · filed 2019-02-28 | $65.56M 10-Q · filed 2018-08-02 | $120.01M derived: sum of 3 quarters · filed 2019-02-28 | $174.35M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||
| 2017-03-31 | $32.45M 10-K · filed 2019-02-28 | $86.90M derived: sum of 2 quarters · filed 2019-02-28 | $141.24M derived: sum of 3 quarters · filed 2019-02-28 | $208.97M derived: sum of 4 quarters · filed 2019-02-28 | ||||||||
| 2016-12-31 | $54.45M 10-K · filed 2018-02-27 | $108.79M derived: sum of 2 quarters · filed 2018-02-27 | $176.52M derived: sum of 3 quarters · filed 2018-02-27 | $251.13M 10-K · filed 2019-02-28 | ||||||||
| 2016-09-30 | $54.34M 10-K · filed 2018-02-27 | $122.07M derived: sum of 2 quarters · filed 2018-02-27 | $196.68M 10-Q · filed 2017-11-02 | $272.67M derived: sum of 4 quarters · filed 2018-02-27 | ||||||||
| 2016-06-30 | $67.73M 10-K · filed 2018-02-27 | $142.34M 10-Q · filed 2017-08-03 | $218.33M derived: sum of 3 quarters · filed 2018-02-27 | $294.47M derived: sum of 4 quarters · filed 2018-02-27 | ||||||||
| 2016-03-31 | $74.61M 10-K · filed 2018-02-27 | $150.60M derived: sum of 2 quarters · filed 2018-02-27 | $226.74M derived: sum of 3 quarters · filed 2018-02-27 | $287.11M derived: sum of 4 quarters · filed 2018-02-27 | ||||||||
| 2015-12-31 | $76.00M 10-K · filed 2017-02-23 | $152.13M derived: sum of 2 quarters · filed 2017-02-23 | $212.50M derived: sum of 3 quarters · filed 2017-02-23 | $269.25M 10-K · filed 2018-02-27 | ||||||||
| 2015-09-30 | $76.14M 10-K · filed 2017-02-23 | $136.51M derived: sum of 2 quarters · filed 2017-02-23 | $193.26M 10-Q · filed 2016-11-04 | $243.41M derived: sum of 4 quarters · filed 2017-02-23 | ||||||||
| 2015-06-30 | $60.37M 10-K · filed 2017-02-23 | $117.12M 10-Q · filed 2016-08-09 | $167.27M derived: sum of 3 quarters · filed 2017-02-23 | $202.23M derived: sum of 4 quarters · filed 2017-02-23 | ||||||||
| 2015-03-31 | $56.75M 10-K · filed 2017-02-23 | $106.90M derived: sum of 2 quarters · filed 2017-02-23 | $141.86M derived: sum of 3 quarters · filed 2017-02-23 | $170.30M derived: sum of 4 quarters · filed 2017-02-23 | ||||||||
| 2014-12-31 | $50.15M 10-K · filed 2016-02-29 | $85.11M derived: sum of 2 quarters · filed 2016-02-29 | $113.55M derived: sum of 3 quarters · filed 2016-02-29 | $137.71M 10-K · filed 2017-02-23 | ||||||||
| 2014-09-30 | $34.97M 10-K · filed 2016-02-29 | $63.41M derived: sum of 2 quarters · filed 2016-02-29 | $87.56M 10-Q · filed 2015-11-06 | $110.10M derived: sum of 4 quarters · filed 2016-02-29 | ||||||||
| 2014-06-30 | $28.44M 10-K · filed 2016-02-29 | $52.59M 10-Q · filed 2015-08-07 | $75.14M derived: sum of 3 quarters · filed 2016-02-29 | $91.20M derived: sum of 4 quarters · filed 2016-02-29 | ||||||||
| 2014-03-31 | $24.15M 10-K · filed 2016-02-29 | $46.70M derived: sum of 2 quarters · filed 2016-02-29 | $62.76M derived: sum of 3 quarters · filed 2016-02-29 | $78.57M derived: sum of 4 quarters · filed 2016-02-29 | ||||||||
| 2013-12-31 | $22.54M 10-K · filed 2015-02-27 | $38.61M derived: sum of 2 quarters · filed 2015-02-27 | $54.42M derived: sum of 3 quarters · filed 2015-02-27 | $66.55M 10-K · filed 2016-02-29 | $190.25M 10-K · filed 2014-02-28 | |||||||
| 2013-09-30 | $16.06M 10-K · filed 2015-02-27 | $31.88M derived: sum of 2 quarters · filed 2015-02-27 | $44.00M 10-Q · filed 2014-11-07 | $62.28M derived: sum of 4 quarters · filed 2015-02-27 | $167.71M 10-Q · filed 2013-11-07 | |||||||
| 2013-06-30 | $15.82M 10-K · filed 2015-02-27 | $27.94M 10-Q · filed 2014-08-08 | $46.22M derived: sum of 3 quarters · filed 2015-02-27 | $61.68M derived: sum of 4 quarters · filed 2015-02-27 | $151.64M 10-Q · filed 2013-08-07 | |||||||
| 2013-03-31 | $12.12M 10-K · filed 2015-02-27 | $30.41M derived: sum of 2 quarters · filed 2015-02-27 | $45.86M derived: sum of 3 quarters · filed 2015-02-27 | $58.45M derived: sum of 4 quarters · filed 2015-02-27 | $135.83M 10-Q · filed 2013-05-08 | |||||||
| 2012-12-31 | $18.28M 10-K · filed 2014-02-28 | $33.74M derived: sum of 2 quarters · filed 2014-02-28 | $46.33M derived: sum of 3 quarters · filed 2014-02-28 | $58.89M 10-K · filed 2015-02-27 | $123.70M 10-K · filed 2013-03-14 | |||||||
| 2012-09-30 | $15.46M 10-K · filed 2014-02-28 | $28.05M derived: sum of 2 quarters · filed 2014-02-28 | $40.61M 10-Q · filed 2013-11-07 | $53.05M derived: sum of 4 quarters · filed 2014-02-28 | $105.42M 10-Q · filed 2012-11-14 | |||||||
| 2012-06-30 | $12.59M 10-K · filed 2014-02-28 | $25.15M 10-Q · filed 2013-08-07 | $37.59M derived: sum of 3 quarters · filed 2014-02-28 | $49.16M derived: sum of 4 quarters · filed 2014-02-28 | $89.96M 10-Q · filed 2012-08-10 | |||||||
| 2012-03-31 | $12.56M 10-K · filed 2014-02-28 | $25.00M derived: sum of 2 quarters · filed 2014-02-28 | $36.57M derived: sum of 3 quarters · filed 2014-02-28 | $46.25M derived: sum of 4 quarters · filed 2014-02-28 | $77.37M 10-Q · filed 2012-05-11 | |||||||
| 2011-12-31 | $12.44M 10-K · filed 2013-03-14 | $24.01M derived: sum of 2 quarters · filed 2013-03-14 | $33.69M derived: sum of 3 quarters · filed 2013-03-14 | $40.73M 10-K · filed 2014-02-28 | ||||||||
| 2011-09-30 | $11.57M 10-K · filed 2013-03-14 | $21.25M derived: sum of 2 quarters · filed 2013-03-14 | $28.29M 10-Q · filed 2012-11-14 | |||||||||
| 2011-06-30 | $9.68M 10-K · filed 2013-03-14 | $16.72M 10-Q · filed 2012-08-10 | ||||||||||
| 2011-03-31 | $7.04M 10-K · filed 2013-03-14 | |||||||||||
| 2010-12-31 | $22.32M 10-K · filed 2013-03-14 |